Nucleix Ltd.
- Country
- ๐ฎ๐ฑIsrael
- Ownership
- Holding
- Established
- 2008-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.nucleix.com
Lung EpiCheck Biomarkers Development Study
- Conditions
- Lung Cancer
- Interventions
- Other: Blood collection
- First Posted Date
- 2024-02-07
- Last Posted Date
- 2024-02-12
- Lead Sponsor
- Nucleix Ltd.
- Target Recruit Count
- 6000
- Registration Number
- NCT06245876
- Locations
- ๐บ๐ธ
Ochsner LSU Health Shreveport - Regional Urology, Shreveport, Louisiana, United States
๐บ๐ธComprehensive Urology, Southfield, Michigan, United States
๐บ๐ธLife Spring Clinical Research, Miami, Florida, United States
Analytical Specificity of Bladder EpiCheck Test in Healthy Population and Urology Patients Without Prior History or Evidence of Bladder Cancer
- Conditions
- Non-Muscle Invasive Bladder Urothelial CarcinomaNon Muscle Invasive Bladder Cancer
- Interventions
- Diagnostic Test: Bladder EpiCheck
- First Posted Date
- 2023-09-01
- Last Posted Date
- 2023-09-07
- Lead Sponsor
- Nucleix Ltd.
- Target Recruit Count
- 168
- Registration Number
- NCT06020807
- Locations
- ๐บ๐ธ
Urology San Antonio, San Antonio, Texas, United States
Determination and Validation of a Multi-analyte Assay for Lung Cancer Screening
- Conditions
- Lung Cancer
- Interventions
- Procedure: Blood collection
- First Posted Date
- 2021-07-20
- Last Posted Date
- 2024-04-01
- Lead Sponsor
- Nucleix Ltd.
- Target Recruit Count
- 5000
- Registration Number
- NCT04968548
- Locations
- ๐บ๐ธ
Cleveland Clinic Foundation, Cleveland, Ohio, United States
๐บ๐ธDurham VA Health Care System, Durham, North Carolina, United States
๐บ๐ธScripps Memorial Hospital, Encinitas, California, United States
Characterization of Methylation Patterns in Cancer and Non-Cancer cfDNA
- Conditions
- CancerHematologic NeoplasmsSolid Tumor
- Interventions
- Procedure: Blood collection
- First Posted Date
- 2020-02-11
- Last Posted Date
- 2022-06-08
- Lead Sponsor
- Nucleix Ltd.
- Target Recruit Count
- 800
- Registration Number
- NCT04264767
- Locations
- ๐ฎ๐ฑ
Sourasky Medical Center, Tel Aviv, Israel
๐บ๐ธLos Angeles Hematology Oncology Medical Group - Wilson Terrace, Glendale, California, United States
๐บ๐ธLos Angeles Hematology Oncology Medical Group - Good Samaritan Medical Offices, Los Angeles, California, United States
Characterization of Methylation Patterns in Hepatocellular Carcinoma
- Conditions
- CirrhosisHepatocellular CarcinomaHepatocellular Cancer
- Interventions
- Procedure: Blood collection
- First Posted Date
- 2020-02-11
- Last Posted Date
- 2021-05-06
- Lead Sponsor
- Nucleix Ltd.
- Target Recruit Count
- 120
- Registration Number
- NCT04264754
- Locations
- ๐ฎ๐ฑ
Rambam Medical Center, Haifa, Israel
๐ฎ๐ฑHa'emek Medical Center, Afula, Israel
๐ฎ๐ฑCarmel Medical Center, Haifa, Israel
The Efficacy of the Bladder EpiCheck for Detection of Recurrent Urothelial Cell Carcinoma
- Conditions
- Bladder Cancer
- Interventions
- Device: Bladder EpiCheck Urine TestProcedure: Cystoscopy and pathology
- First Posted Date
- 2016-03-07
- Last Posted Date
- 2021-05-04
- Lead Sponsor
- Nucleix Ltd.
- Target Recruit Count
- 680
- Registration Number
- NCT02700464
- Locations
- ๐บ๐ธ
Vanderbilt University Medical Center, Nashville, Tennessee, United States
๐บ๐ธThe Urology Center of Colorado, Denver, Colorado, United States
๐บ๐ธUrological Surgeons of Long Island, Garden City, New York, United States
Utility of Bladder EpiCheck for Detection of Recurrent Urothelial Carcinoma
- Conditions
- Bladder Cancer
- Interventions
- Other: Bladder EpiCheck
- First Posted Date
- 2016-01-06
- Last Posted Date
- 2021-05-04
- Lead Sponsor
- Nucleix Ltd.
- Target Recruit Count
- 1050
- Registration Number
- NCT02647112
- Locations
- ๐ฉ๐ช
Tubingen University Medical Center, Tubingen, Germany
๐ณ๐ฑZGT Medical Center, Hengelo, Netherlands
๐ณ๐ฑRadboud University Medical Center, Nijmegen, Netherlands
Characterization of Methylation Patterns in Lung Cancer
- Conditions
- Lung Cancer
- First Posted Date
- 2015-02-27
- Last Posted Date
- 2021-05-04
- Lead Sponsor
- Nucleix Ltd.
- Target Recruit Count
- 683
- Registration Number
- NCT02373917
- Locations
- ๐ฎ๐ฑ
Sha'are Tzedaek Medical Center, Jerusalem, Israel